Endothelial Cell Selective Adhesion Molecule
ESAMproteinESAM is an endothelial-cell adhesion molecule marking activation and integrity loss after coronary intervention.
Pathway placement
Cascade stepEndothelial activation & erosion
Confidencemedium
RationaleEndothelial activation marker; reflects endothelial dysfunction post-PCI.
Also acts inVascular inflammation
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableYes
EnsemblENSG00000149564
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I33
C — confounder / Type-II40
A — assay feasibility68
E — evidence strength17
T1DI (composite)5
Specificity differential (R−C)-6.8
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(1)
- Analysis of biomarkers for risk of acute kidney injury after primary angioplasty for acute ST-segment elevation myocardial infarction: results of the HORIZONS-AMI trial.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2014 · PMID 25130788 · doi